VRDN FY 2015 Earnings — Viridian Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VRDNViridian Therapeutics, Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-41.3% YoY

Gross Profit

$66,0002.6% margin

Operating Income

-$11M-440.8% margin

Net Income

-$11M-446.3% margin

EPS (Diluted)

$-21.00

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$13M

Total Liabilities

$2M

Stockholders' Equity

$10M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-41.3%
Gross Profit	$66,000	$1M	-93.9%
Operating Income	-$11M	-$7M	-62.9%
Net Income	-$11M	-$8M	-43.6%